NIH VideoCast - Race and the Molecular Biology Of Breast Cancer: A Pathologist’s View From the Bench to the Bedside

Skip Navigation

Race and the Molecular Biology Of Breast Cancer: A Pathologist’s View From the Bench to the Bedside

Loading... Loading video...

604 Views

Air date:	Wednesday, March 4, 2020, 3:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 604 (158 Live, 446 On-demand)
Category:	WALS - Wednesday Afternoon Lectures
Runtime:	01:05:58
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	NIH Director’s Wednesday Afternoon Lecture Series Dr. Gardner is a clinically trained pathologist that studies chromatin based-mechanism of transcriptional control in both cancers of lymphoid and epithelial origin. Recently we have refocused the efforts in my lab to define and reveal how alteration and/or disruption of gene regulation contributes to cancer incidence, evolution, and outcome. An essential and overarching goal of this effort is to translate the biological implications of these observations into principles and tenets that will have a broader impact on the molecular understanding of disease. The ultimate objective is to provide new strategies for improving the diagnosis, treatment, and prevention of cancer. To accomplish this my lab incorporates molecular, biochemical, and cell biological methodology with genome-wide bioinformatics and computational technology to assemble a research portfolio that leverages multi-disciplinary translational applications, to define molecular links between race, lifestyle, the environment, and disease. Dr. Gardner's lab incorporates molecular, biochemical, and cell biological methodology with genome-wide bioinformatics and computational technology to assemble a research portfolio that leverages multi-disciplinary translational applications to define molecular links between race, lifestyle, the environment, and disease.

NLM Title:	Race and the molecular biology of breast cancer : a pathologist's view from the bench to the bedside / Kevin L. Gardner.
Author:	Gardner, Kevin. National Institutes of Health (U.S.),
Publisher:
Abstract:	(CIT): NIH Director"s Wednesday Afternoon Lecture Series Dr. Gardner is a clinically trained pathologist that studies chromatin based-mechanism of transcriptional control in both cancers of lymphoid and epithelial origin. Recently we have refocused the efforts in my lab to define and reveal how alteration and/or disruption of contributes to cancer incidence, evolution, and outcome. An essential and overarching goal of this effort is to translate the biological implications of these observations into principles and tenets that will have a broader impact on the molecular understanding of disease. The ultimate objective is to provide new strategies for improving the diagnosis, treatment, and prevention of cancer. To accomplish this his lab incorporates molecular, biochemical, and cell biological methodology with genome-wide bioinformatics and computational technology to assemble a research portfolio that leverages multi-disciplinary translational applications, to define molecular links between race, lifestyle, the environment, and disease. Dr. Gardner's lab incorporates molecular, biochemical, and cell biological methodology with genome-wide bioinformatics and computational technology to assemble a research portfolio that leverages multi-disciplinary translational applications to define molecular links between race, lifestyle, the environment, and disease.
Subjects:	Breast Neoplasms--genetics Breast Neoplasms--pathology Epidemiologic Factors Pathology, Molecular--methods Socioeconomic Factors
Publication Types:	Lecture Webcast

NLM Classification:	WP 870
NLM ID:	101765811
CIT Live ID:	36079
Permanent link:	https://videocast.nih.gov/watch=36079

Related Videos...